Thu, 24 Sep 2020 12:16:56: Lumen bags U.S. grant for GI-focused COVID-19 antibody cocktail

Thu, 24 Sep 2020 11:43:23: Poxel posts phase 3 diabetes data ahead of approval decision

Thu, 24 Sep 2020 10:30:42: Agios helps identify genes that allow cancer to escape the immune system

Thu, 24 Sep 2020 08:24:14: Moderna's COVID-19 vaccine investigator leaves FDA advisory committee over conflict of interest

Wed, 23 Sep 2020 12:50:23: FDA to set high bar for emergency COVID-19 vaccine approvals

Wed, 23 Sep 2020 12:37:00: Roche, AC Immune's tau-blocking drug flops in Alzheimer's as biotech's shares halved

Wed, 23 Sep 2020 11:56:18: J&J starts COVID-19 vaccine phase 3, eyes early 2021 approval

Wed, 23 Sep 2020 10:27:09: New insights into the coronavirus spike protein could inspire vaccine development

Wed, 23 Sep 2020 01:45:02: 4th time's the charm: Longitude Capital raises $585M in its largest-ever fund

Tue, 22 Sep 2020 13:07:31: FDA grants priority review to ide-cel, keeping Bristol Myers on track to deliver Celgene payday

Tue, 22 Sep 2020 12:07:08: Medicxi raises €200M to take 6 biotechs deeper into the clinic

Tue, 22 Sep 2020 07:37:52: IPO, check: Now, ADC Therapeutics files for lonca approval

Tue, 22 Sep 2020 01:44:44: Emmecell exits stealth mode as FDA greenlights clinical trials of cornea cell therapy

Mon, 21 Sep 2020 12:20:34: Flagship Pioneering's 2-becomes-one biotech nabs ex-Pfizer CSO as research lead

Mon, 21 Sep 2020 12:03:57: Bischofberger's Kronos files for IPO to run pivotal cancer trial

Mon, 21 Sep 2020 12:03:45: ESMO: Blueprint preps trial of drug targeting triple-mutant EGFR in lung cancer backed by mouse data

Mon, 21 Sep 2020 11:09:23: ESMO: Adding Elevar's EGFR drug to AstraZeneca's Iressa boosts survival in early lung cancer

Mon, 21 Sep 2020 10:18:28: Boosting immuno-oncology drugs by recruiting immune messenger cells

Mon, 21 Sep 2020 09:42:34: Roche pays €380M for NLRP3 biotech Inflazome, claiming a leading position in hot field 

Fri, 18 Sep 2020 15:44:00: ESMO: Roche's Akt inhibitor scores slight win over J&J's Zytiga

Fri, 18 Sep 2020 15:36:55: ESMO: Novartis posts data from failed spartalizumab phase 3, reaffirms commitment to PD-1 combos

Fri, 18 Sep 2020 15:24:52: ESMO: Chi-Med's surufatinib gears up to challenge Novartis, Pfizer with placebo-topping phase 3

Fri, 18 Sep 2020 13:50:31: ESMO: Early days, but Amgen's BiTE drug in prostate cancer shows encouraging activity

Fri, 18 Sep 2020 12:23:55: Under pressure, Pfizer, Moderna (and soon AstraZeneca) publish COVID-19 vaccine protocols

Fri, 18 Sep 2020 11:58:54: Roden, fresh from BMS-Celgene merger, lands VC role at MPM